QSI is testing the upper boundary of its descending channel around $1.70, which aligns with the 78.6% Fib retracement from the recent swing. A clean break above $1.72 with volume could trigger a move toward $2.00, where heavy sell blocks are stacked.
Key levels to watch: • Breakout trigger: $1.72+ • Resistance zones: $2.00–$2.15, then $2.50 • Support: $1.60, $1.53 (200-day MA) • RSI: Neutral (~48), MACD turning slightly positive • Short interest: ~17% – potential for squeeze on breakout
If bulls reclaim $2.15, a run toward $2.50–$3.00 becomes more likely, though that zone has heavy supply. Watching volume closely.
QSI so the universe giving us a chance to load up. Thanks to the Feud. Elon vs President.
Whoever follows me, DCA your open position to get better exit. And buy some good momentum stocks. We can exit by next week to make good money. Both big boys will eventually settle. Market will be green
1. First-Mover in Protein Sequencing • QSI is aiming to do for proteins what Illumina did for DNA. • Their Sapphire platform can potentially democratize proteomics by making it faster, cheaper, and more accessible. 2. Massive Market Opportunity • The proteomics market is expected to reach ~$80B by 2030. • Drug development, diagnostics, and personalized medicine all rely increasingly on protein-level data. 3. Platform Play, Not a One-Off Product • If successful, QSI could become a core platform in labs like Thermo Fisher or Illumina—leading to high-margin recurring revenue. 4. Tech Validation by Former Illumina Founder • Jonathan Rothberg, who founded Illumina and Butterfly Network, is behind QSI. His track record brings credibility.
QSI 
